Dual functional molecular imaging probe targeting CD20 with PET and optical imaging.

The present study aimed to develop a monoclonal antibody (mAb)-based double functional probe for PET and near-infrared fluorescence (NIRF) targeting CD20 and to cross validate the targeting efficacy of this dual functional probe. NuB2, anti CD20 mAb was conjugated with Alexa Fluor 750 and 64Cu through DOTA chelator. PET and NIRF imaging was carried out at 30 min and 24 h post-injection with 64Cu-DOTA-NuB2-Alexa Fluor 750 in CD20 positive Raji lymphoma-bearing mice. Fluorescence intensity and radio-activity were studied by ex vivo biodistribution study at 30 min, 24 and 48 h after injection. Raji tumor showed significantly higher uptake of DOTA-NuB2-Alexa Fluor 750 than that of DOTA-Alexa Fluor 750 (p<0.05). Significant correlation was obtained between the organ-to-muscle ratios measured by the radioactivity and fluorescence intensity (p<2.2e-16, r=0.94). Our findings demonstrate the effectiveness and feasibility of preparing an effective mAb-based dual functional imaging agent for PET and NIRF targeting the CD20 expression in lymphoma.

[1]  Kai Chen,et al.  Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  Weibo Cai,et al.  Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.

[3]  S. Achilefu,et al.  Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities , 2008, Journal of Nuclear Medicine.

[4]  Sanjiv S. Gambhir,et al.  Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature , 2007, Journal of Nuclear Medicine.

[5]  Eva M. Sevick-Muraca,et al.  Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer , 2007, Journal of Nuclear Medicine.

[6]  Sanjiv S Gambhir,et al.  microPET-Based Biodistribution of Quantum Dots in Living Mice , 2007, Journal of Nuclear Medicine.

[7]  Shi Ke,et al.  A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. , 2007, Bioconjugate chemistry.

[8]  Chun Li,et al.  Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. , 2006, Nuclear medicine and biology.

[9]  H. Hanaoka,et al.  Current status of cancer therapy with radiolabeled monoclonal antibody , 2005, Annals of nuclear medicine.

[10]  E. Sevick-Muraca,et al.  Near-Infrared Fluorescence Optical Imaging and Tomography , 2004, Disease markers.

[11]  Chun Li,et al.  Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. , 2003, Cancer research.

[12]  M. Welch,et al.  In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  R. N. Goble,et al.  Performance evaluation of the microPET R4 PET scanner for rodents , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  M. Welch,et al.  In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. , 2000, Bioconjugate chemistry.

[15]  R Weissleder,et al.  Near-infrared optical imaging of protease activity for tumor detection. , 1999, Radiology.

[16]  M J Welch,et al.  Copper-64-labeled antibodies for PET imaging. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.